Tagged with USA

New US ‘Biosecure Act’ to Target Chinese Biotechs WuXi and BGI
2023 FDA Drug Approvals: Second Highest Count in 30 Years
JP Morgan 2024 In Review: Good Vibrations
A Call for Collective Responsibility in Rare Disease Communities
The IRA & Uncertain Times for US Pharma
Faced with IRA Challenges, BIO Names New CEO: Washington Fixture John Crowley
The Evolution of US FDA Diversity Requirements in Clinical Research
Eli Lilly: The World’s First Trillion-Dollar Pharma Company?
All Change at the Top: 13 New Pharma CEOs in 2023
New NIH Director Bertagnolli to Focus on Access
New FDA Guidance Addresses Challenges with Cell and Gene Manufacturing Comparability and Complexity
Rob Abbott – CEO & Executive Director, ISPOR
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here